
Axogen Stock Soars 23% to Intraday High Amid Strong Market Activity
2025-10-30 19:28:13Axogen, Inc. has seen notable stock performance, with significant gains over various timeframes, including a 59.38% increase over the past year. Despite challenges in long-term fundamentals, the company enjoys strong institutional support, reflecting confidence from investors in its market position within the Pharmaceuticals & Biotechnology sector.
Read More
Axogen, Inc. Hits New 52-Week High of $22.95, Surges 217.86%
2025-10-30 18:46:01Axogen, Inc. has achieved a new 52-week high of USD 22.95, reflecting a significant year-over-year performance increase. With a market capitalization of USD 738 million, the company operates in a competitive sector but is currently not generating profits and does not offer dividends, focusing on growth instead.
Read More
Axogen, Inc. Experiences Evaluation Revision Amidst Shifting Market Dynamics and Performance Indicators
2025-10-07 19:22:08Axogen, Inc. has recently revised its evaluation amid changing market dynamics. The stock is priced at $17.16, with a notable one-year return of 25.53%, outperforming the S&P 500. Various technical indicators show mixed signals, reflecting the company's resilience and performance trends in the competitive landscape.
Read MoreIs Axogen, Inc. technically bullish or bearish?
2025-10-07 12:22:59As of 3 October 2025, the technical trend for Axogen, Inc. has changed from mildly bullish to bullish. The current stance is bullish, with strength indicated by a bullish MACD on the weekly chart and bullish moving averages on the daily timeframe. However, the weekly RSI is bearish, suggesting some short-term weakness. The Bollinger Bands and KST are both mildly bullish on the weekly, while the Dow Theory shows no trend on the weekly but mildly bullish on the monthly. In terms of performance, Axogen has outperformed the S&P 500 over the past month with a return of 7.38% compared to the S&P's 4.15%, but it has lagged behind over the longer term, particularly in the 3-year and 5-year periods....
Read More
Axogen Stock Forms Golden Cross, Signaling Potential Bullish Breakout Ahead
2025-10-06 15:14:55Axogen, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. The stock has outperformed the S&P 500 over the past year and shows positive short-term trends. Despite mixed signals from other indicators, overall bullish trends suggest strong investor interest in the company.
Read MoreIs Axogen, Inc. technically bullish or bearish?
2025-10-06 12:13:04As of 3 October 2025, the technical trend for Axogen, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals across time frames. The weekly RSI is bearish, but the monthly RSI shows no signal. Bollinger Bands are bullish on both weekly and monthly charts, and daily moving averages are also bullish. The KST is bullish weekly but mildly bearish monthly, and Dow Theory shows a mildly bullish stance on both weekly and monthly time frames. The OBV is bullish in both time frames. In terms of performance, Axogen has outperformed the S&P 500 over the past year with a return of 34.03% compared to the S&P 500's 17.82%, but it has lagged behind over longer periods, particularly in the 3Y and 5Y returns. Overall, the current technical stance is bullish, driven by strong weekly indicators despite some mixed monthly signals....
Read MoreIs Axogen, Inc. technically bullish or bearish?
2025-10-05 11:58:19As of 3 October 2025, the technical trend for Axogen, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed momentum. The weekly RSI is bearish, but the monthly RSI shows no signal. Bollinger Bands are bullish on both weekly and monthly time frames, supporting the bullish stance. Daily moving averages are also bullish. The KST shows a bullish weekly trend but is mildly bearish monthly, and Dow Theory indicates a mildly bullish stance in both time frames. The OBV is bullish across both weekly and monthly periods. In terms of performance, Axogen has outperformed the S&P 500 over the past year with a return of 34.03% compared to the S&P 500's 17.82%, but it has lagged over the longer three and five-year periods. Overall, the current technical stance is bullish, driven by strong weekly indicators despite some mixed signals in the...
Read More
Axogen, Inc. Experiences Evaluation Revision Amid Mixed Performance Indicators and Market Dynamics
2025-09-22 18:12:09Axogen, Inc. has recently revised its evaluation amid fluctuating market conditions, with its stock priced at $17.20. The company has shown significant volatility over the past year, with mixed technical indicators and performance that has outpaced the S&P 500 in shorter time frames, but lagged over longer periods.
Read MoreIs Axogen, Inc. technically bullish or bearish?
2025-09-20 19:51:13As of 11 September 2025, the technical trend for Axogen, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish. The weekly RSI is bearish, and the daily moving averages are mildly bearish. However, the Bollinger Bands and KST indicators are bullish on both weekly and monthly time frames, and Dow Theory indicates a mildly bullish stance for both periods. In terms of returns, Axogen has outperformed the S&P 500 over the past week and month, with returns of 2.74% and 11.43% respectively, while the S&P 500 returned 1.05% and 2.33%. However, over longer periods, Axogen has underperformed the S&P 500, particularly in the 3-year and 5-year periods. Overall, the current technical stance is mildly bullish, driven by the positive signals from Bollinger Bands and KST, despite some bearish indicators in the RSI and moving averages....
Read More





